Cover Image
市場調查報告書

Can-Fite BioPharma Ltd. - 產品平台分析

Can-Fite BioPharma Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226303
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Can-Fite BioPharma Ltd. - 產品平台分析 Can-Fite BioPharma Ltd. - Product Pipeline Review - 2015
出版日期: 2015年04月29日 內容資訊: 英文 33 Pages
簡介

Can-Fite BioPharma Ltd. ha,是致力開發發炎性疾病、癌症、性功能障礙和眼病的治療藥的生物製藥公司。該公司的產品使用於類風濕性關節炎、青光眼、乾癬、肝癌、發炎性疾病等的治療。

本報告提供Can-Fite BioPharma Ltd.的治療藥開發平台的現狀及各開發階段比較分析、藥物標的、作用機制、給藥途徑、各分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Can-Fite BioPharma Ltd.的基本資料

Can-Fite BioPharma Ltd.概要

  • 主要資訊
  • 企業資料

Can-Fite BioPharma Ltd.:R&D概要

  • 主要的治療範圍

Can-Fite BioPharma Ltd.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Can-Fite BioPharma Ltd.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式

Can-Fite BioPharma Ltd.:藥物簡介

  • CF-101
  • CF-102
  • CF-602

Can-Fite BioPharma Ltd.:開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Can-Fite BioPharma Ltd.:最近的開發平台趨勢

Can-Fite BioPharma Ltd.:暫停中的計劃

Can-Fite BioPharma Ltd.:開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • CF-101
    • CF-502

Can-Fite BioPharma Ltd.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07040CDB

Summary

Global Markets Direct's, 'Can-Fite BioPharma Ltd. - Product Pipeline Review - 2015', provides an overview of the Can-Fite BioPharma Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Can-Fite BioPharma Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Can-Fite BioPharma Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Can-Fite BioPharma Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Can-Fite BioPharma Ltd.'s pipeline products

Reasons to buy

  • Evaluate Can-Fite BioPharma Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Can-Fite BioPharma Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Can-Fite BioPharma Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Can-Fite BioPharma Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Can-Fite BioPharma Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Can-Fite BioPharma Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Can-Fite BioPharma Ltd. Snapshot
    • Can-Fite BioPharma Ltd. Overview
    • Key Information
    • Key Facts
  • Can-Fite BioPharma Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Can-Fite BioPharma Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Can-Fite BioPharma Ltd. - Pipeline Products Glance
    • Can-Fite BioPharma Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Can-Fite BioPharma Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Can-Fite BioPharma Ltd. - Drug Profiles
    • CF-101
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CF-102
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CF-602
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Can-Fite BioPharma Ltd. - Pipeline Analysis
    • Can-Fite BioPharma Ltd. - Pipeline Products by Target
    • Can-Fite BioPharma Ltd. - Pipeline Products by Route of Administration
    • Can-Fite BioPharma Ltd. - Pipeline Products by Molecule Type
    • Can-Fite BioPharma Ltd. - Pipeline Products by Mechanism of Action
  • Can-Fite BioPharma Ltd. - Recent Pipeline Updates
  • Can-Fite BioPharma Ltd. - Dormant Projects
  • Can-Fite BioPharma Ltd. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • CF-101
      • CF-502
  • Can-Fite BioPharma Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Can-Fite BioPharma Ltd., Key Information
  • Can-Fite BioPharma Ltd., Key Facts
  • Can-Fite BioPharma Ltd. - Pipeline by Indication, 2015
  • Can-Fite BioPharma Ltd. - Pipeline by Stage of Development, 2015
  • Can-Fite BioPharma Ltd. - Monotherapy Products in Pipeline, 2015
  • Can-Fite BioPharma Ltd. - Phase II, 2015
  • Can-Fite BioPharma Ltd. - Phase I, 2015
  • Can-Fite BioPharma Ltd. - Preclinical, 2015
  • Can-Fite BioPharma Ltd. - Pipeline by Target, 2015
  • Can-Fite BioPharma Ltd. - Pipeline by Route of Administration, 2015
  • Can-Fite BioPharma Ltd. - Pipeline by Molecule Type, 2015
  • Can-Fite BioPharma Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Can-Fite BioPharma Ltd. - Recent Pipeline Updates, 2015
  • Can-Fite BioPharma Ltd. - Dormant Developmental Projects,2015
  • Can-Fite BioPharma Ltd. - Discontinued Pipeline Products, 2015
  • Can-Fite BioPharma Ltd., Other Locations
  • Can-Fite BioPharma Ltd., Subsidiaries

List of Figures

  • Can-Fite BioPharma Ltd. - Pipeline by Top 10 Indication, 2015
  • Can-Fite BioPharma Ltd. - Pipeline by Stage of Development, 2015
  • Can-Fite BioPharma Ltd. - Monotherapy Products in Pipeline, 2015
  • Can-Fite BioPharma Ltd. - Pipeline by Top 10 Target, 2015
  • Can-Fite BioPharma Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Can-Fite BioPharma Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Can-Fite BioPharma Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top